Loading...
Please wait, while we are loading the content...
Similar Documents
Pin1 Clinical and Economic Impact of Introducing a Quadrivalent (6, 11, 16, 18) Human Papillomavirus Vaccine in Switzerland
| Content Provider | Semantic Scholar |
|---|---|
| Author | Wein, Aj Summerhayes |
| Copyright Year | 2010 |
| Abstract | compare return to baseline (RTB) for HRQoL. A seven point difference (considered to be clinically significant) between baseline and follow-up score was considered as RTB. RESULTS: ANOVA indicated that RP group had higher scores for generic HRQoL subscales of physical function (p = 0.019), role emotional (p = 0.037), vitality (p = 0.033) and general health (p = 0.05). Stepwise log-linear regression models showed that RP was associated with higher 12 month scores for most of the generic HRQoL scales, bowel function (OR = 1.12), urinary bother (OR = 1.6) and bowel bother (OR = 1.5). For generic HRQoL (SF-36) at 12 month follow-up, higher proportion of the RP group returned to baseline on eight sub-scales. RP group had lower proportion returning to baseline for urinary (p = 0.0012) and sexual (p =< 0.0001) functions, and higher proportion returning to baseline for bowel function, urinary bother and bowel bother (p =< 0.005). Satisfaction with care was comparable between treatment groups. CONCLUSIONS: Older patients appear to have better tolerance for RP as indicated by patient reported outcomes. Thus age alone need not be a criterion in treatment decision. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://core.ac.uk/download/pdf/82706050.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
